Medison Pharma Ltd.
10 Hashiloach Street
P.O. Box 7090
18 articles with Medison Pharma Ltd.
Medison Pharma and Alpha Tau Medical Announce a Collaboration in the Oncology Field in Central and Eastern Europe
Medison Pharma Trading AG, a fully owned subsidiary of Medison Pharma Ltd., and Alpha Tau Medical Ltd., the developer of a breakthrough alpha-radiation cancer therapy "Alpha DaRT," are pleased to announce an exploratory collaboration in the oncology field in Central and Eastern Europe.
- Biohaven and Medison Pharma's partnership will bring NURTEC ODT, the first oral, quick-dissolve, calcitonin gene related peptide (CGRP) antagonist to patients in Israel - Registration in Israel based upon Biohaven's NURTEC ODT approval in the US
BridgeBio Pharma’s Origin Biosciences Enters Partnership With Medison to Commercialize BBP-870 in Israel for MoCD Type A
BridgeBio Pharma, Inc. and Medison Pharma Ltd. have entered into an exclusive license agreement under which Medison received rights from Origin to distribute, market, sell and otherwise commercialize Origin’s drug product known as fosdenopterin in Israel..
Medison Urges Fellow Shareholders to Bring Positive Change to Knight Therapeutics by Voting for All Six of Medison's Highly Qualified Nominees at Upcoming Annual Meeting
Failures at Knight have been exposed by multiple, independent third parties
ISS Notes "Stark" Underperformance, Recommends Election of New Independent Directors and for Knight Shareholders to Vote on the GOLD Proxy Card
Puma Biotechnology and Medison Pharma Enter into Exclusive Licensing Agreement to Commercialize NERLYNX (neratinib) in Israel
Puma Biotechnology, a biopharmaceutical company, and Medison Pharma Ltd. Israel's leading commercial partner for innovative pharmaceuticals, have entered into an exclusive agreement under which Medison will commercialize NERLYNX® (neratinib) in Israel.
Alliance to focus on regulatory approval, commercialization and marketing of novel apabetalone therapy in Israel.
Gentium S.p.A. Signs License and Distribution Agreement for Defibrotide With Medison Pharma Ltd. in Israel and the Palestinian Authority
Corgenix Medical Corporation Partners with Medison Pharma Ltd. to Bring Aspirinworks Urine Tests For Heart Disease Sufferers To Israel
Medison Pharma Ltd. And Cepheid Sign Agreement: Automated Genetic Testing Systems For The Israeli Market
AutoGenomics' Automated Multiplexing Molecular Diagnostic Platform Available In Israel Through Medison Pharma Ltd.
PharmAthene, Inc. Signs Agreement with Medison Pharma Ltd. to Commercialize and Distribute Biodefense Medical Countermeasures in Israel
IDM Pharma, Inc. And Medison Pharma Ltd. Sign An Exclusive Marketing Agreement For Junovan(TM) In Israel